Literature DB >> 19005633

Unusual paraneoplastic syndromes of breast carcinoma: a combination of cerebellar degeneration and Lambert-Eaton Myasthenic Syndrome.

L Romics1, B McNamara, P A Cronin, M E O'Brien, N Relihan, H P Redmond.   

Abstract

INTRODUCTION: Paraneoplastic neurological disorders are rare complications of breast carcinoma. Lambert-Eaton Myasthenic Syndrome (LEMS) is most commonly associated with small cell lung cancer. However, a combination of LEMS and subacute cerebellar degeneration as paraneoplastic syndromes is extremely rare, and has never been described in association with breast cancer. CASE: We report for the first time an unusual association of LEMS and paraneoplastic subacute cerebellar degeneration with breast carcinoma.
CONCLUSION: In patients with atypical LEMS, when there is no evidence of respiratory malignancy, breast cancer should be included in the differential diagnosis.

Entities:  

Mesh:

Year:  2008        PMID: 19005633     DOI: 10.1007/s11845-008-0257-5

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  6 in total

1.  Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

Authors:  W P Mason; F Graus; B Lang; J Honnorat; J Y Delattre; F Valldeoriola; J C Antoine; M K Rosenblum; M R Rosenfeld; J Newsom-Davis; J B Posner; J Dalmau
Journal:  Brain       Date:  1997-08       Impact factor: 13.501

2.  Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome.

Authors:  Shin J Oh; Katsumi Kurokawa; Gwen C Claussen; Hewitt F Ryan
Journal:  Muscle Nerve       Date:  2005-10       Impact factor: 3.217

3.  Paraneoplastic syndromes associated with lung cancer: a unique case of concomitant subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome.

Authors:  B M Leonovicz; E A Gordon; C T Wass
Journal:  Anesth Analg       Date:  2001-12       Impact factor: 5.108

4.  P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.

Authors:  Paul W Wirtz; Bethan Lang; Francesc Graus; Arn M J M van den Maagdenberg; Albert Saiz; Pia A de Koning Gans; Albert Twijnstra; Jan J G M Verschuuren
Journal:  J Neuroimmunol       Date:  2005-07       Impact factor: 3.478

Review 5.  Lambert-eaton myasthenic syndrome: diagnosis and treatment.

Authors:  Donald B Sanders
Journal:  Ann N Y Acad Sci       Date:  2003-09       Impact factor: 5.691

Review 6.  Paraneoplastic neurological disorders in breast cancer.

Authors:  G Gatti; S Simsek; A Kurne; S Zurrida; P Naninato; P Veronesi; A Frasson; E Millen; J Rososchansky; A Luini
Journal:  Breast       Date:  2003-06       Impact factor: 4.380

  6 in total
  3 in total

Review 1.  Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.

Authors:  Benedikt Schoser; Bruno Eymard; Joe Datt; Renato Mantegazza
Journal:  J Neurol       Date:  2017-06-12       Impact factor: 4.849

2.  Lambert-eaton myasthenic syndrome; pathogenesis, diagnosis, and therapy.

Authors:  Nils Erik Gilhus
Journal:  Autoimmune Dis       Date:  2011-09-29

3.  Lambert-Eaton Myasthenic Syndrome Associated with Synchronous Double Cancer: A Combination of Small Cell Carcinoma of the Cervix and Breast Carcinoma.

Authors:  Hiroyuki Fukuda; Akira Tanaka; Yasuyuki Hirashima; Ichiro Ito
Journal:  Intern Med       Date:  2018-03-09       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.